Nitric oxide and cGMP modulation of extraocular muscle contraction.
Kaminski
Henry J
HJ
Department of Neurology and Neurosciences, Case Western Reserve University School of Medicine, Louis Stokes Veterans Affairs Medical Center, University Hospital of Cleveland, Cleveland, Ohio 44106, USA. hjk3@po.cwru.edu
Richmonds
Chelliah R
CR
D000634:Aminoquinolines / Q000494:pharmacology; D000818:Animals; D006152:Cyclic GMP / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors; D007537:Isometric Contraction / Q000502:physiology*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D009569:Nitric Oxide / Q000502:physiology*; D009801:Oculomotor Muscles / Q000502:physiology*; D051381:Rats; D011917:Rats, Inbred Lew
D000634:Aminoquinolines; D004791:Enzyme Inhibitors; C016276:8-bromocyclic GMP; D009569:Nitric Oxide; C041715:6-anilino-5,8-quinolinedione; D006162:Guanylate Cyclase; D006152:Cyclic GMP; D019331:NG-Nitroarginine Methyl Ester